We appreciate your donation!

Donations over $2 or more are tax-deductible.

CCF Australia is a professional ‘Patient-Centric’ and ‘Patient-Led’ Organisation, that places the needs of the patient and their caregiver first.

Stage 4 Survivor, Founder
Cholangiocarcinoma Foundation Australia
Our lives really do depend on your support. 

When we are diagnosed, we do not know what we do not know, but absolutely must as quickly as possible. This is where our Australia Foundation steps in and helps bridge such a crucial gap. We are a Professional Patient-Led Cancer Research and Advocacy Organisation (Charity) that ensures today’s medical research benefits today’s patient survival.

Steve Holmes
Chief Executive
Cholangiocarcinoma Foundation Australia
+61 415153522
steve@cholangio.org

Projects you are supporting

CCA Digital Toolkits

Support the evolution of our all-screen digital toolkits tailored for CCA patients: Toolkits provide the optimal cancer patient pathway and your contributions will fuel the continuous development and maintenance of these invaluable resources. Invest in this transformative initiative and join us in empowering patients on their journey against cholangiocarcinoma.

Patient CCA Journals

Support our patient empowerment initiative. Your contribution will enable the production and free distribution of our invaluable toolkit and navigator journals – the optimal cancer patient pathway.

Remote 2nd Opinions

Support our ‘2nd Opinion Project’ – a critical patient-first initiative. Your contribution will enable remote access to diagnosis-specific medical experts for cholangiocarcinoma patients across Australia, promoting second or third opinions. Donate today to help solve a significant challenge and potentially save lives. Join us in putting patients first.

Patient Registry & Genomic Portal

Support our CCA-specific Patient Registry and Portal. Your donation helps patients contribute their diagnosis and genetic data, enhancing our understanding and paving the way for more accurate response initiatives. Fund this critical patient initiative today and join us in revolutionising cholangiocarcinoma care.